The University of Chicago Header Logo

Connection

Sarosh Rana to Adult

Back to Details
This is a "connection" page, showing publications Sarosh Rana has written about Adult.
Sarosh Rana
Connection Strength
1.835
Adult
  1. Effect of postpartum oral furosemide use on postpartum readmissions and blood pressure trends. Pregnancy Hypertens. 2025 Mar; 39:101199.
    View in: PubMed
    Score: 0.056
  2. A 26-Year-Old Woman with Postpartum Abdominal Pain. NEJM Evid. 2025 Feb; 4(2):EVIDmr2400398.
    View in: PubMed
    Score: 0.056
  3. Neonatal cost savings in hypertensive disorders of pregnancy: Economic evaluation of the sFlt-1/PlGF test with real world implementation of biomarkers. Pregnancy Hypertens. 2025 Mar; 39:101190.
    View in: PubMed
    Score: 0.056
  4. Systematic treatment and management of postpartum hypertension using remote patient monitoring. Pregnancy Hypertens. 2025 Mar; 39:101180.
    View in: PubMed
    Score: 0.056
  5. Real-world evidence for the utility of serum soluble fms-like tyrosine kinase 1/placental growth factor test for routine clinical evaluation of hospitalized women with hypertensive disorders of pregnancy. Am J Obstet Gynecol. 2025 Apr; 232(4):385.e1-385.e21.
    View in: PubMed
    Score: 0.054
  6. Patient perceptions of remote patient monitoring program for hypertensive disorders of pregnancy. Arch Gynecol Obstet. 2024 09; 310(3):1563-1576.
    View in: PubMed
    Score: 0.054
  7. Extended postpartum outcomes with systematic treatment of and management of postpartum hypertension program. Pregnancy Hypertens. 2024 Sep; 37:101138.
    View in: PubMed
    Score: 0.054
  8. Discharge medication delivery location and postpartum blood pressure control in patients with hypertensive disorders of pregnancy. Pregnancy Hypertens. 2024 Jun; 36:101125.
    View in: PubMed
    Score: 0.053
  9. Signs or symptoms of suspected preeclampsia - A retrospective national database study of prevalence, costs, and outcomes. Pregnancy Hypertens. 2024 Jun; 36:101124.
    View in: PubMed
    Score: 0.053
  10. Prevalence and management of severe intrapartum hypertension in patients with preeclampsia at an urban tertiary care medical center. Pregnancy Hypertens. 2022 Mar; 27:87-93.
    View in: PubMed
    Score: 0.045
  11. Postpartum Outcomes With Systematic Treatment and Management of Postpartum Hypertension. Obstet Gynecol. 2021 11 01; 138(5):777-787.
    View in: PubMed
    Score: 0.045
  12. Cost effectiveness of the sFlt1/PlGF ratio test as an adjunct to the current practice of evaluating suspected preeclampsia in the United States. Pregnancy Hypertens. 2021 Dec; 26:121-126.
    View in: PubMed
    Score: 0.045
  13. The interval between births and the risk of recurrent preeclampsia among predominantly high risk women in urban tertiary care center. Pregnancy Hypertens. 2021 Aug; 25:7-11.
    View in: PubMed
    Score: 0.043
  14. Real life outpatient biomarker use in management of hypertensive pregnancies in third trimester in a low resource SeTting: ROBUST study. Pregnancy Hypertens. 2021 Mar; 23:97-103.
    View in: PubMed
    Score: 0.042
  15. Evaluation of angiogenic factors in the decision to admit women with suspected preeclampsia. Pregnancy Hypertens. 2020 Jul; 21:124-131.
    View in: PubMed
    Score: 0.041
  16. Angiogenic factor abnormalities and risk of peripartum complications and prematurity among urban predominantly obese parturients with chronic hypertension. Pregnancy Hypertens. 2020 Apr; 20:124-130.
    View in: PubMed
    Score: 0.040
  17. Effect of blood pressure control in early pregnancy and clinical outcomes in African American women with chronic hypertension. Pregnancy Hypertens. 2020 Apr; 20:102-107.
    View in: PubMed
    Score: 0.040
  18. Severe antepartum hypertension and associated peripartum morbidity among pregnant women in an urban tertiary care medical center. Pregnancy Hypertens. 2020 Jan; 19:31-36.
    View in: PubMed
    Score: 0.039
  19. Understanding and comparing practices of managing patients with hypertensive disorders of pregnancy in urban China and the United States. Pregnancy Hypertens. 2019 Jul; 17:253-260.
    View in: PubMed
    Score: 0.038
  20. Angiogenic Factor Estimation as a Warning Sign of Preeclampsia-Related Peripartum Morbidity Among Hospitalized Patients. Hypertension. 2019 04; 73(4):868-877.
    View in: PubMed
    Score: 0.037
  21. Association of antepartum blood pressure levels and angiogenic profile among women with chronic hypertension. Pregnancy Hypertens. 2018 Oct; 14:110-114.
    View in: PubMed
    Score: 0.036
  22. Activin A and Late Postpartum Cardiac Dysfunction Among Women With Hypertensive Disorders of Pregnancy. Hypertension. 2018 07; 72(1):188-193.
    View in: PubMed
    Score: 0.035
  23. Angiogenic biomarkers in triage and risk for preeclampsia with severe features. Pregnancy Hypertens. 2018 Jul; 13:100-106.
    View in: PubMed
    Score: 0.035
  24. Abnormal mid-trimester cardiac strain in women with chronic hypertension predates superimposed preeclampsia. Pregnancy Hypertens. 2017 Oct; 10:251-255.
    View in: PubMed
    Score: 0.034
  25. Prevalence, risk factors and associated complications of postpartum hypertension in rural Haiti. Pregnancy Hypertens. 2017 Oct; 10:135-142.
    View in: PubMed
    Score: 0.033
  26. Circulating Antiangiogenic Factors and Myocardial Dysfunction in Hypertensive Disorders of Pregnancy. Hypertension. 2016 06; 67(6):1273-80.
    View in: PubMed
    Score: 0.031
  27. KRYPTOR-automated angiogenic factor assays and risk of preeclampsia-related adverse outcomes. Hypertens Pregnancy. 2016 Aug; 35(3):330-45.
    View in: PubMed
    Score: 0.030
  28. Sequential plasma angiogenic factors levels in women with suspected preeclampsia. Am J Obstet Gynecol. 2016 Jul; 215(1):89.e1-89.e10.
    View in: PubMed
    Score: 0.030
  29. Epidemiology and Mechanisms of De Novo and Persistent Hypertension in the Postpartum Period. Circulation. 2015 Nov 03; 132(18):1726-33.
    View in: PubMed
    Score: 0.029
  30. Modeling risk for severe adverse outcomes using angiogenic factor measurements in women with suspected preterm preeclampsia. Prenat Diagn. 2015 Apr; 35(4):386-93.
    View in: PubMed
    Score: 0.028
  31. Placental lesions of vascular insufficiency are associated with anti-angiogenic state in women with preeclampsia. Hypertens Pregnancy. 2014 Nov; 33(4):427-39.
    View in: PubMed
    Score: 0.027
  32. Clinical characterization and outcomes of preeclampsia with normal angiogenic profile. Hypertens Pregnancy. 2013 May; 32(2):189-201.
    View in: PubMed
    Score: 0.025
  33. Plasma concentrations of soluble endoglin versus standard evaluation in patients with suspected preeclampsia. PLoS One. 2012; 7(10):e48259.
    View in: PubMed
    Score: 0.024
  34. Circulating lymphangiogenic factors in preeclampsia. Hypertens Pregnancy. 2013; 32(1):42-9.
    View in: PubMed
    Score: 0.024
  35. Circulating angiogenic factors and risk of adverse maternal and perinatal outcomes in twin pregnancies with suspected preeclampsia. Hypertension. 2012 Aug; 60(2):451-8.
    View in: PubMed
    Score: 0.023
  36. Angiogenic factors and pregnant woman with new onset seizures. Hypertens Pregnancy. 2012; 31(2):207-10.
    View in: PubMed
    Score: 0.023
  37. Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia. Circulation. 2012 Feb 21; 125(7):911-9.
    View in: PubMed
    Score: 0.023
  38. Placental origins of angiogenic dysfunction in mirror syndrome. Hypertens Pregnancy. 2012; 31(2):211-7.
    View in: PubMed
    Score: 0.023
  39. The use of angiogenic biomarkers to differentiate non-HELLP related thrombocytopenia from HELLP syndrome. J Matern Fetal Neonatal Med. 2010 May; 23(5):366-70.
    View in: PubMed
    Score: 0.020
  40. Rupture of the posterior cul-de-sac during spontaneous labor. Obstet Gynecol. 2010 Feb; 115(2 Pt 2):414-417.
    View in: PubMed
    Score: 0.020
  41. Sequential changes in antiangiogenic factors in early pregnancy and risk of developing preeclampsia. Hypertension. 2007 Jul; 50(1):137-42.
    View in: PubMed
    Score: 0.016
  42. Cytomegalovirus-induced mirror syndrome associated with elevated levels of circulating antiangiogenic factors. Obstet Gynecol. 2007 Feb; 109(2 Pt2):549-52.
    View in: PubMed
    Score: 0.016
  43. Neuropsychological performance in normal pregnancy and preeclampsia. Am J Obstet Gynecol. 2006 Jul; 195(1):186-91.
    View in: PubMed
    Score: 0.015
  44. Impact of PlGF immunoassay imprecision on preeclampsia risk assessment with the sFlt-1 to PlGF ratio. Am J Clin Pathol. 2025 Aug 26; 164(2):200-206.
    View in: PubMed
    Score: 0.015
  45. Reference Range Determination for the sFlt-1/PlGF Ratio in a Diverse Cohort of Pregnant Women in the United States. J Appl Lab Med. 2025 Jul 01; 10(4):937-948.
    View in: PubMed
    Score: 0.014
  46. Circulating follistatin-like 3 and its association with postpartum cardiovascular dysfunction and severe maternal morbidity. Pregnancy Hypertens. 2025 Jun; 40:101206.
    View in: PubMed
    Score: 0.014
  47. Plasma soluble fms-like tyrosine kinase 1 to placental growth factor ratio of 11.5 multiples of median predicts preeclampsia with severe features within 2 weeks of testing. Am J Obstet Gynecol. 2024 Sep; 231(3):363.e1-363.e11.
    View in: PubMed
    Score: 0.013
  48. Report from a text-based blood pressure monitoring prospective cohort trial among postpartum women with hypertensive disorders of pregnancy. BMC Pregnancy Childbirth. 2024 May 03; 24(1):340.
    View in: PubMed
    Score: 0.013
  49. Stage IIIC small cell carcinoma of the ovary: survival with conservative surgery and chemotherapy. Obstet Gynecol. 2004 May; 103(5 Pt 2):1120-3.
    View in: PubMed
    Score: 0.013
  50. Angiogenic factors and prediction for ischemic placental disease in future pregnancies. Pregnancy Hypertens. 2021 Aug; 25:12-17.
    View in: PubMed
    Score: 0.011
  51. Genetic and Phenotypic Landscape of Peripartum Cardiomyopathy. Circulation. 2021 05 11; 143(19):1852-1862.
    View in: PubMed
    Score: 0.011
  52. Long-Term Postpartum Cardiac Function and Its Association With Preeclampsia. J Am Heart Assoc. 2021 02; 10(5):e018526.
    View in: PubMed
    Score: 0.011
  53. Antepartum Aspirin Administration Reduces Activin A and Cardiac Global Longitudinal Strain in Preeclamptic Women. J Am Heart Assoc. 2020 06 16; 9(12):e015997.
    View in: PubMed
    Score: 0.010
  54. Hypertensive Diseases of Pregnancy Increase Risk of Readmission With Heart Failure: A National Readmissions Database Study. Mayo Clin Proc. 2019 05; 94(5):811-819.
    View in: PubMed
    Score: 0.009
  55. Household air pollution and chronic hypoxia in the placenta of pregnant Nigerian women: A randomized controlled ethanol Cookstove intervention. Sci Total Environ. 2018 Apr 01; 619-620:212-220.
    View in: PubMed
    Score: 0.009
  56. Outcomes and mortality in parturient and non-parturient patients with peripartum cardiomyopathy: A national readmission database study. Pregnancy Hypertens. 2017 Oct; 10:143-148.
    View in: PubMed
    Score: 0.008
  57. Increased Perinatal Morbidity and Mortality Among Asian American and Pacific Islander Women in the United States. Anesth Analg. 2017 03; 124(3):879-886.
    View in: PubMed
    Score: 0.008
  58. Myocardial performance index in hypertensive disorders of pregnancy: The relationship between blood pressures and angiogenic factors. Hypertens Pregnancy. 2017 May; 36(2):161-167.
    View in: PubMed
    Score: 0.008
  59. Cardiogenic shock in pregnancy: Analysis from the National Inpatient Sample. Hypertens Pregnancy. 2017 May; 36(2):117-123.
    View in: PubMed
    Score: 0.008
  60. Gelsolin is an endogenous inhibitor of syncytiotrophoblast extracellular vesicle shedding in pregnancy. Pregnancy Hypertens. 2016 Oct; 6(4):333-339.
    View in: PubMed
    Score: 0.008
  61. Trophoblast mitochondrial function is impaired in preeclampsia and correlates negatively with the expression of soluble fms-like tyrosine kinase 1. Pregnancy Hypertens. 2016 Oct; 6(4):313-319.
    View in: PubMed
    Score: 0.008
  62. Relaxin-2 and Soluble Flt1 Levels in Peripartum Cardiomyopathy: Results of the Multicenter IPAC Study. JACC Heart Fail. 2016 05; 4(5):380-8.
    View in: PubMed
    Score: 0.008
  63. Angiogenic factor imbalance early in pregnancy predicts adverse outcomes in patients with lupus and antiphospholipid antibodies: results of the PROMISSE study. Am J Obstet Gynecol. 2016 Jan; 214(1):108.e1-108.e14.
    View in: PubMed
    Score: 0.007
  64. The association of circulating angiogenic factors and HbA1c with the risk of preeclampsia in women with preexisting diabetes. Hypertens Pregnancy. 2014 Feb; 33(1):81-92.
    View in: PubMed
    Score: 0.006
  65. Relationship between nulliparity and preeclampsia may be explained by altered circulating soluble fms-like tyrosine kinase 1. Hypertens Pregnancy. 2014 May; 33(2):250-9.
    View in: PubMed
    Score: 0.006
  66. The course of angiogenic factors in early- vs. late-onset preeclampsia and HELLP syndrome. J Perinat Med. 2013 Sep 01; 41(5):511-6.
    View in: PubMed
    Score: 0.006
  67. Subclinical left ventricular dysfunction in preeclamptic women with preserved left ventricular ejection fraction: a 2D speckle-tracking imaging study. Circ Cardiovasc Imaging. 2012 Nov; 5(6):734-9.
    View in: PubMed
    Score: 0.006
  68. Mid-pregnancy levels of angiogenic markers as indicators of pathways to preterm delivery. J Matern Fetal Neonatal Med. 2012 Jul; 25(7):1135-41.
    View in: PubMed
    Score: 0.006
  69. Placental expression of angiogenic factors in Trisomy 13. Am J Obstet Gynecol. 2011 Jun; 204(6):546.e1-4.
    View in: PubMed
    Score: 0.005
  70. Preeclampsia and the risk of large-for-gestational-age infants. Am J Obstet Gynecol. 2011 May; 204(5):425.e1-6.
    View in: PubMed
    Score: 0.005
  71. Midpregnancy levels of angiogenic markers in relation to maternal characteristics. Am J Obstet Gynecol. 2011 Mar; 204(3):244.e1-12.
    View in: PubMed
    Score: 0.005
  72. First trimester vitamin D, vitamin D binding protein, and subsequent preeclampsia. Hypertension. 2010 Oct; 56(4):758-63.
    View in: PubMed
    Score: 0.005
  73. Early-pregnancy soluble Fas levels in idiopathic small-for-gestational-age pregnancies. Am J Obstet Gynecol. 2010 Mar; 202(3):299.e1-7.
    View in: PubMed
    Score: 0.005
  74. Risk for developing gestational diabetes in women with twin pregnancies. J Matern Fetal Neonatal Med. 2009 Apr; 22(4):293-9.
    View in: PubMed
    Score: 0.005
  75. Circulating soluble endoglin and placental abruption. Prenat Diagn. 2008 Sep; 28(9):852-8.
    View in: PubMed
    Score: 0.004
  76. Use of circulating antiangiogenic factors to differentiate other hypertensive disorders from preeclampsia in a pregnant woman on dialysis. Am J Kidney Dis. 2008 Jun; 51(6):1029-32.
    View in: PubMed
    Score: 0.004
  77. Circulating levels of the antiangiogenic marker soluble FMS-like tyrosine kinase 1 are elevated in women with pregestational diabetes and preeclampsia: angiogenic markers in preeclampsia and preexisting diabetes. Diabetes Care. 2007 Feb; 30(2):375-7.
    View in: PubMed
    Score: 0.004
  78. Fetal cheek-to-cheek diameter in the prediction of mode of delivery. Am J Obstet Gynecol. 2005 Apr; 192(4):1205-11; discussion 1211-3.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.